Pebblebrook Hotel Trust (PEB) Stock Price & Analysis
Pebblebrook Hotel Trust (PEB) closed at USD 20.67 on Thursday, October 22, 2026, down 2.04% on the day. The US market is currently closed (pre-market); this is not a live price.
The prior close was USD 21.1; the Oct 22, 2026 session ranged USD 20.62–21.26 on volume of 3,269,256 shares. Market capitalization is $2.33B, with a 52-week range of USD 9.99–21.26 (NYQ). Source: Nexqual, retrieved October 23, 2026 at 10:06 UTC.
Also available as compact Markdown for AI agents: nexqual.com/PEB.md
Key facts (PEB)
- Last four reported quarters (through Jun 30, 2026): revenue $1.50B, net income -$46.6M (-3.1% margin), free cash flow $207M (SEC filings).
- Insider open-market sales, last ~7 months: 1 Form 4 filings, $770K; 1 not under a Rule 10b5-1 plan ($770K); 0 by opportunistic insiders, 0 by routine insiders (three-year test, Cohen, Malloy & Pomorski 2012).
- Insider open-market purchases, last ~7 months: 3 Form 4 filings, $1.7M; 0 by opportunistic insiders, 3 by routine insiders.
- Analysts: Hold (mean 3.00 on a 1–5 scale) (16 analysts), mean target USD 19.5 (range 15–22).
- Total return with dividends: 1Y +92.6% vs S&P 500 +14.9%; 5Y -4.6% vs S&P 500 +80.3%.
- Next earnings: 2026-10-29, EPS estimate USD -0.02, revenue estimate $388M.
Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters) (PEB)
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM |
|---|---|---|---|---|---|---|
| Revenue | $733M | $1.39B | $1.42B | $1.45B | $1.48B | $1.50B |
| Operating income | -$89.8M | $14.7M | $37.8M | $84.0M | $43.8M | $63.9M |
| Net income | -$185M | -$87.2M | -$78.0M | -$4.2M | -$65.8M | -$46.6M |
| EPS (diluted) | -$1.80 | -$0.95 | -$0.93 | -$0.39 | -$0.90 | — |
| Free cash flow | — | — | $35.6M | $146M | $152M | $207M |
| Operating margin | -12.2% | 1.1% | 2.7% | 5.8% | 3.0% | 4.3% |
| Net margin | -25.2% | -6.3% | -5.5% | -0.3% | -4.5% | -3.1% |
| Revenue growth | +65.5% | +89.9% | +2.0% | +2.3% | +1.5% | — |
| Cash + short-term investments | $58.5M | $41.0M | $184M | $207M | $184M | — |
| Total debt | $2.44B | $2.39B | $2.32B | $2.25B | $2.12B | — |
Fiscal years end Dec. EPS is split-adjusted.
Valuation (price ÷ last four quarters, through Jun 30, 2026) (PEB)
P/S 1.6x · EV/Sales 2.8x · P/FCF 11.3x · P/B 1.0x · FCF yield 8.87% · Earnings yield -2.00% · Dividend yield (paid, TTM) 0.20% · Buyback yield (TTM) 3.04% · Net debt $1.82B · EV $4.15B
Insider sales (SEC Form 4, open-market, last ~7 months) (PEB)
0 of 1 under a Rule 10b5-1 trading plan (scheduled in advance). Unplanned sales were timed by the insider.
| Trade date | Insider | Role | Shares | Value | % of holdings sold | 10b5-1 plan | Insider type |
|---|---|---|---|---|---|---|---|
| 2026-08-03 | Fisher Thomas Charles | Co-President, C Investmt Ofcr | 40,000 | $770K | 12.3% | No | Too little history (no open-market trades in 2023 or 2025) |
% of holdings sold = shares sold ÷ (shares sold + all holdings the insider reported on that Form 4, direct and through trusts).
Insider type follows Cohen, Malloy & Pomorski (Journal of Finance, 2012). An insider who traded the stock in the same calendar month in each of the past three years is a routine trader; one who traded in each of those years without such a pattern is an opportunistic trader. In their study, trades by opportunistic insiders predicted future returns and trades by routine insiders did not. Counts open-market purchases and sales only (SEC Form 4 codes P and S) by that insider in that company. Not investment advice.
Insider purchases (SEC Form 4, open-market, last ~7 months) (PEB)
3 purchases, $1.7M. Private placements, offerings, dividend reinvestment and employee stock purchase plan buys are excluded.
| Trade date | Insider | Role | Shares | Value | Avg price | Insider type |
|---|---|---|---|---|---|---|
| 2026-06-12 | Bortz Jon E | Chairman and CEO | 20,000 | $364K | 18.18 | Routine (bought in Jun each year 2023–2025) |
| 2026-06-10…2026-06-11 | Bortz Jon E | Chairman and CEO | 40,000 | $699K | 17.48 | Routine (bought in Jun each year 2023–2025) |
| 2026-06-08…2026-06-09 | Bortz Jon E | Chairman and CEO | 40,000 | $679K | 16.96 | Routine (bought in Jun each year 2023–2025) |
Analysts (PEB)
Consensus Hold (mean 3.00 on a 1–5 scale), 16 analysts; mean target USD 19.5 (low 15, high 22).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-10-22 | Morgan Stanley | Target raised | Underweight | $14 → $15 |
| 2026-10-12 | Morgan Stanley | Target raised | Underweight | $13 → $14 |
| 2026-09-28 | Raymond James | Target raised | Outperform | $18 → $20 |
| 2026-08-27 | Barclays | Target lowered | Underweight | $15 → $14 |
| 2026-08-11 | Cantor Fitzgerald | Target raised | Neutral | $15 → $19 |
| 2026-07-31 | Ladenburg Thalmann | Target raised | Neutral | $19 → $21 |
| 2026-07-31 | Compass Point | Upgrade | Sell → Neutral | $19.5 |
| 2026-07-30 | Stifel | Target raised | Buy | $20.25 → $21.25 |
| 2026-07-28 | Evercore ISI Group | Target raised | In-Line | $17 → $20 |
| 2026-07-23 | Wells Fargo | Target raised | Equal-Weight | $16 → $19 |
| 2026-07-22 | Citigroup | Target raised | Neutral | $15 → $20 |
| 2026-07-21 | Barclays | Target raised | Underweight | $13 → $15 |
Total return (dividends reinvested) (PEB)
| 1Y (from 2025-10-23) | 5Y (from 2021-10-18) | |
|---|---|---|
| Total return | +92.6% | -4.6% |
| S&P 500 (SPY) | +14.9% | +80.3% |
| Per year | +93.1% | -0.9% |
| Volatility (annualized) | 31.6% | 37.9% |
| Max drawdown | -12.2% (Feb 2026→Mar 2026) | -66.9% (Nov 2021→Mar 2025) |
PEB revenue by product line (quarter ended Jun 30, 2026)
| Line | Revenue | Share of total | YoY |
|---|---|---|---|
| Room | $259.7M | 63.8% | +0.8% |
| Food and beverage | $102.6M | 25.2% | -3.2% |
| Other operating | $44.9M | 11.0% | +2.1% |
| Total revenue | $407.1M | 100% | — |
PEB revenue by region (quarter ended Jun 30, 2026)
| Line | Revenue | Share of total | YoY |
|---|---|---|---|
| San Diego, CA | $91.3M | 22.4% | +5.3% |
| Boston, MA | $81.9M | 20.1% | +1.1% |
| Southern Florida/Georgia | $76.2M | 18.7% | +7.4% |
| Los Angeles, CA | $44.5M | 10.9% | -0.3% |
| San Francisco, CA | $41.0M | 10.1% | +9.8% |
| Other | $31.9M | 7.8% | -29.1% |
| Portland, OR | $21.7M | 5.3% | +0.4% |
| Washington, D.C. | $18.7M | 4.6% | -8.5% |
| Total revenue | $407.1M | 100% | — |
As tagged by the company in its SEC 10-Q / 10-K filings (XBRL).
PEB suppliers, customers and competitors (named in its 10-K)
| Relationship | Company | Sentence in the filing |
|---|---|---|
| Partner | Pebblebrook Hotel | “Substantially all of the Company's assets are held by, and all of the Company's operations are conducted through, Pebblebrook Hotel, L.P. (our "Operating Partnership").” |
| Competitor | Airbnb (ABNB) | “Additional sources of competition, such as alternative lodging marketplaces like Airbnb, may, as they become more accepted, lead to a reduced demand for conventional hotel guest rooms and to an increased supply of lodging alternatives.” |
Quoted from the company's 10-K filed Feb 25, 2026.
PEB company outlook (results filed Jul 29, 2026)
- “Outlook, while Same-Property Total Expenses rose just 3.8%.”
- “The Company also completed its property insurance renewal on June 1, 2026, securing a 27% premium reduction, or $6.1 million in annual savings, versus the prior year's program—a result that was better than anticipated.”
Quoted word-for-word from the SEC 8-K results press release.
PEB analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends Sep 2026) | $-0.02 | $0.05 | -140.0% | $388.3M | 2 |
| Next quarter (ends Dec 2026) | $-0.24 | $-0.17 | +44.1% | $343.4M | 2 |
| Current fiscal year (ends Dec 2026) | $-0.28 | $-0.56 | -50.0% | $1.49B | 2 |
| Next fiscal year (ends Dec 2027) | $-0.27 | $-0.36 | -24.3% | $1.51B | 3 |
PEB options: expected move
Options price a move of about ±14.4% (±$2.98) by Nov 20, 2026, which includes earnings on Oct 29, 2026. Over the last 8 reports the stock moved ±3.5% on average.
| Expiration | Days | ATM implied volatility | Expected move |
|---|---|---|---|
| Nov 20, 2026 | 28 | 64.3% | ±14.4% |
| Dec 18, 2026 | 56 | 46.5% | ±14.8% |
| Mar 19, 2027 | 147 | 46.7% | ±23.5% |
| Jun 17, 2027 | 237 | 42.4% | ±26.9% |
30-day implied volatility 49.9% vs 23% realized over the last 30 trading days. Put/call ratio (volume) 0. Cboe delayed quotes (15 min). Expected move = at-the-money straddle.
Key Statistics (as of October 23, 2026 at 10:06 UTC)
| Price | USD 20.67 |
|---|---|
| Change | ▼ 2.04% (down) |
| Previous Close | USD 21.1 |
| Open | USD 20.8 |
| Day Range | USD 20.62 – 21.26 |
| 52-Week Range | USD 9.99 – 21.26 |
| Volume | 3,269,256 shares |
| Market Cap | $2.33B |
| Exchange | NYQ |
Technical Analysis (PEB)
Nexqual's technical model rates PEB "BUY" based on 5 bullish and 1 bearish signals across 127 daily candles, as of October 23, 2026 at 10:06 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 68.89 (neutral) |
| vs SMA50 | Above (USD 18.63) |
| MACD | 0.57 (positive) |
Analyst Ratings (PEB)
Wall Street analysts rate PEB "Hold" based on 16 analysts, with a mean price target of USD 19.5 (range USD 15–22), per Nexqual as of October 23, 2026 at 10:06 UTC.
| Consensus Rating | Hold |
|---|---|
| Analyst Count | 16 |
| Mean Target | USD 19.5 |
| High Target | USD 22 |
| Low Target | USD 15 |
| Buy / Hold / Sell | 4 / 9 / 3 |
Earnings (PEB)
| Next Earnings Date | 2026-10-29 |
|---|---|
| EPS Estimate | USD -0.02 |
| Revenue Estimate | $388.28M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-06-30 | USD 0.17 vs est 0.11 ▲ beat |
| 2026-03-31 | USD -0.23 vs est -0.34 ▲ beat |
| 2025-12-31 | USD -0.23 vs est -0.31 ▲ beat |
| 2025-09-30 | USD -0.37 vs est -0.02 ▼ miss |
Source: Nexqual, October 23, 2026 at 10:06 UTC.
Financials & Fundamentals (PEB)
| Total Revenue | $1.50B |
|---|---|
| Revenue Growth (latest quarter, YoY) | -0.10% |
| Gross Margin | +25.34% |
| Operating Margin | +14.33% |
| Profit Margin | -3.11% |
| ROE | -1.63% |
| Debt / Equity | 0.98 |
| Current Ratio | 0.71 |
| Total Cash | $267.21M |
| Total Debt | $2.46B |
| Free Cash Flow (last four quarters to Jun 2026, SEC 10-Q / 10-K) | $206.90M (13.8% of revenue) |
Source: Nexqual, October 23, 2026 at 10:06 UTC.
Financial Health Score (PEB)
Nexqual rates Pebblebrook Hotel Trust's overall financial health "Mixed" across five dimensions, as of October 23, 2026 at 10:06 UTC.
| Growth | Mixed — Revenue +1.5% YoY (annual), slow |
|---|---|
| Profitability | Solid — Gross margin 25%, operating 14% (last 12 months) |
| Balance Sheet | Weak — $261M cash and investments vs $2.08B debt (Jun 2026, SEC) |
| Cash Flow | Solid — FCF $207M (last 4 quarters to Jun 2026, SEC), 14% margin |
| Efficiency | Critical — ROE -2%, ROA 1.3% |
Ownership (PEB)
| Insider Ownership | +2.58% |
|---|---|
| Institutional Ownership | +131.37% |
| Shares Outstanding | 112.84M |
| Float | 109.91M |
| Short % of Float | +28.45% |
Source: Nexqual, October 23, 2026 at 10:06 UTC.
Leadership (PEB)
Pebblebrook Hotel Trust is led by Jon E. Bortz, Chairman & CEO, per Nexqual as of October 23, 2026 at 10:06 UTC.
| Chairman & CEO | Jon E. Bortz |
|---|---|
| Co-President, CFO, Treasurer & Secretary | Raymond D. Martz |
| Co-President & Chief Investment Officer | Thomas Charles Fisher |
Major Backers & Investors (PEB)
Notable institutional backers of Pebblebrook Hotel Trust include Price (T.Rowe) Associates Inc, T. Rowe Price, TR PRICE-Price (T.Rowe) Real Assets Trust I, according to Nexqual as of October 23, 2026 at 10:06 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Price (T.Rowe) Associates Inc | 7.6% |
| T. Rowe Price | 4.83% |
| TR PRICE-Price (T.Rowe) Real Assets Trust I | 4.63% |
| Arrowstreet Capital, Limited Partnership | 4.17% |
| Earnest Partners LLC | 4.02% |
| Bank of America Corporation | 3.26% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| BlackRock | 17.64% |
| Vanguard Group | 14.38% |
| State Street | 5.72% |
| Geode Capital | 3.17% |
Source: Nexqual, October 23, 2026 at 10:06 UTC.
From Pebblebrook Hotel Trust's Latest SEC 10-K Filing (filed 2026-02-25)
Partnerships
- We generally seek to enter into flexible management contracts, when possible, with third-party hotel management companies for the operation of our hotels and resorts that provide us with the ability to replace operators and/or reposition properties, to the extent that we determine to do so and align our operators with our objective of maximizing our return on investment.
Legal & Regulatory Risks (Item 1A, quoted)
- Compliance with the Americans with Disabilities Act could require us to incur substantial costs.
- The nature of the operations of our hotels exposes us to the risk of claims and litigation that may arise in the normal course of business.
- The costs of compliance with or liabilities under environmental laws could significantly reduce our profitability.
- We may be subject to adverse legislative or regulatory tax changes that could increase our tax liability, reduce the tax benefits of our REIT structure compared to non-REIT corporations, reduce our operating flexibility and reduce the market price of our shares.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| SHO | Sunstone Hotel Investors, Inc. | USD 12.6 | ▼ 0.08% |
| XHR | Xenia Hotels & Resorts, Inc. | USD 19.5 | ▼ 0.66% |
| DRH | Diamondrock Hospitality Company | USD 13.89 | ▼ 0.39% |
| RLJ | RLJ Lodging Trust | USD 12.14 | ▼ 1.3% |
| PK | Park Hotels & Resorts Inc. | USD 16.66 | ▼ 1.94% |
| APLE | Apple Hospitality REIT, Inc. | USD 18.16 | ▲ 0.06% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 23, 2026 at 10:06 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt